Table 1.

Effect of Amblyomin-X in cell viability of different tumor cell lines

Tumor cell line	Origin	Viability
Mia-PaCa-2	Human pancreatic adenocarcinoma	67.02 ± 5.9***
Panc1	Human pancreatic epithelioid carcinoma	35.81 ± 1.2**
AsPC1	Human pancreatic adenocarcinoma	29.56 ± 1.03**
BxPC3	Human pancreatic adenocarcinoma	13.89 ± 0.50**
SK-MEL-28	Human melanoma	43.91 ± 10.5**
SK-MEL-5	Human melanoma	42.34 ± 13.75**
Human Fibroblast	Non-tumor cell	106.76 ± 10.01

Tumor cells lines were incubated with 1 µM of Amblyomin-X for 48 h, and cell viability was assessed as described in Materials and Methods. The data presented as the mean ± SD of three independent experiments

**p ≤ 0.005, ***p ≤ 0.001 compared with the control group (corresponding untreated cells), as determined by one-way ANOVA